Close Menu

NEW YORK – Demand for Thermo Fisher Scientific's products and services around the response to COVID-19 remains strong, a trend the company expects to continue into 2021 and beyond.

On Wednesday, Thermo Fisher reported $2 billion in third quarter revenues related to the COVID-19 response, accounting for 23 percent of its overall revenues and 31 percent of the firm's 36 percent growth in the quarter.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.